- Home
- TRVI vs ZVRA Comparison
TRVI vs ZVRA Comparison
Compare TRVI & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- ZVRA
- Stock Information
- Founded
- TRVI 2011
- ZVRA 2006
- Country
- TRVI United States
- ZVRA United States
- Employees
- TRVI N/A
- ZVRA N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TRVI Health Care
- ZVRA Health Care
- Exchange
- TRVI Nasdaq
- ZVRA Nasdaq
- Market Cap
- TRVI 383.4M
- ZVRA 381.0M
- IPO Year
- TRVI 2019
- ZVRA 2015
- Fundamental
- Price
- TRVI $6.07
- ZVRA $7.15
- Analyst Decision
- TRVI Strong Buy
- ZVRA Strong Buy
- Analyst Count
- TRVI 8
- ZVRA 8
- Target Price
- TRVI $17.56
- ZVRA $22.29
- AVG Volume (30 Days)
- TRVI 1.6M
- ZVRA 542.5K
- Earning Date
- TRVI 05-06-2025
- ZVRA 05-07-2025
- Dividend Yield
- TRVI N/A
- ZVRA N/A
- EPS Growth
- TRVI N/A
- ZVRA N/A
- EPS
- TRVI N/A
- ZVRA N/A
- Revenue
- TRVI N/A
- ZVRA $23,612,000.00
- Revenue This Year
- TRVI N/A
- ZVRA $267.44
- Revenue Next Year
- TRVI N/A
- ZVRA $90.10
- P/E Ratio
- TRVI N/A
- ZVRA N/A
- Revenue Growth
- TRVI N/A
- ZVRA N/A
- 52 Week Low
- TRVI $2.30
- ZVRA $4.20
- 52 Week High
- TRVI $7.39
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- TRVI 54.54
- ZVRA 45.68
- Support Level
- TRVI $4.85
- ZVRA $6.77
- Resistance Level
- TRVI $6.15
- ZVRA $7.22
- Average True Range (ATR)
- TRVI 0.50
- ZVRA 0.45
- MACD
- TRVI -0.04
- ZVRA -0.00
- Stochastic Oscillator
- TRVI 73.94
- ZVRA 61.74
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.